JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB247992

Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Recombinant Monoclonal Interferon alpha/beta receptor 1 antibody. Carrier free. Suitable for WB and reacts with Human samples. Cited in 2 publications.

View Alternative Names

IFNAR, IFNAR1, Interferon alpha/beta receptor 1, IFN-R-1, IFN-alpha/beta receptor 1, Cytokine receptor class-II member 1, Cytokine receptor family 2 member 1, Type I interferon receptor 1, CRF2-1

6 Images
Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)
  • WB

Unknown

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)

This data was developed using ab124764, the same antibody clone in a different buffer formulation.

All lanes:

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] (<a href='/en-us/products/primary-antibodies/interferon-alpha-beta-receptor-1-antibody-epr6244-ab124764'>ab124764</a>) at 1/1000 dilution

Lane 1:

HeLa cell lysate at 10 µg

Lane 2:

HeLa cell lysate treated with IFN-alpha at 10 µg

Lane 3:

K562 cell lysate at 10 µg

Lane 4:

U937 cell lysate at 10 µg

Secondary

All lanes:

Goat anti-Rabbit HRP at 1/200 dilution

Predicted band size: 64 kDa

false

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)
  • WB

Lab

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)

This data was developed using ab124764, the same antibody clone in a different buffer formulation. Western blot : Anti-IFNAR1 antibody [EPR6244] (ab124764) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab124764 was shown to bind specifically to IFNAR1. A band was observed at 116 kDa in wild-type HeLa cell lysates with no signal observed at this size in IFNAR1 knockout cell line. To generate this image, wild-type and IFNAR1 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] (<a href='/en-us/products/primary-antibodies/interferon-alpha-beta-receptor-1-antibody-epr6244-ab124764'>ab124764</a>) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human IFNAR1 (Interferon alpha/beta receptor 1) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-ifnar1-interferon-alpha-beta-receptor-1-knockout-hela-cell-line-ab261782'>ab261782</a>)

Lane 2:

IFNAR1 knockout HeLa cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Predicted band size: 64 kDa

Observed band size: 116 kDa

false

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)
  • WB

Lab

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)

This data was developed using ab124764, the same antibody clone in a different buffer formulation.

Blocking and dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] (<a href='/en-us/products/primary-antibodies/interferon-alpha-beta-receptor-1-antibody-epr6244-ab124764'>ab124764</a>) at 1/1000 dilution

Lane 1:

HEK-293 whole cell lysate at 10 µg

Lane 2:

HeLa whole cell lysate at 10 µg

Lane 3:

LNCaP whole cell lysate at 10 µg

Lane 4:

SH-SY5Y whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 64 kDa

Observed band size: 90-130 kDa

false

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)
  • WB

Lab

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)

This data was developed using ab124764, the same antibody clone in a different buffer formulation.

Blocking and dilution buffer : 5% NFDM/TBST.

In mouse and rat tissue lysates this product detects a band in the region of 100 kDa, however we believe this band is non-specific and is not interferon receptor alpha as the immunogen for this antibody shares only 55% homology with the mouse and rat protein. In addition this band also migrates at a lower molecular weight than that detected in human samples.

All lanes:

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] (<a href='/en-us/products/primary-antibodies/interferon-alpha-beta-receptor-1-antibody-epr6244-ab124764'>ab124764</a>) at 1/1000 dilution

Lane 1:

Mouse brain tissue lysate at 10 µg

Lane 2:

Rat brain tissue lysate at 10 µg

Predicted band size: 64 kDa

Observed band size: 90 kDa

false

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)
  • WB

Lab

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)

This data was developed using ab124764, the same antibody clone in a different buffer formulation.

Blocking and dilution buffer : 5% NFDM/TBST.

In mouse and rat tissue lysates this product detects a band in the region of 100 kDa, however we believe this band is non-specific and is not interferon receptor alpha as the immunogen for this antibody shares only 55% homology with the mouse and rat protein. In addition this band also migrates at a lower molecular weight than that detected in human samples.

All lanes:

Western blot - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] (<a href='/en-us/products/primary-antibodies/interferon-alpha-beta-receptor-1-antibody-epr6244-ab124764'>ab124764</a>) at 1/1000 dilution

Lane 1:

Mouse brain whole tissue lysate at 10 µg

Lane 2:

Mouse heart whole tissue lysate at 10 µg

Lane 3:

Mouse kidney whole tissue lysate at 10 µg

Lane 4:

Mouse spleen whole tissue lysate at 10 µg

Lane 5:

Rat brain whole tissue lysate at 10 µg

Lane 6:

Rat heart whole cell lysate at 10 µg

Lane 7:

Rat kidney whole cell lysate at 10 µg

Lane 8:

Rat spleen whole tissue lysate at 10 µg

Secondary

All lanes:

Goat anti-rabbit IgG (H+L), peroxidase conjugated at 1/2000 dilution

Predicted band size: 64 kDa

false

Exposure time: 3min

OI-RD Scanning - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-Interferon alpha/beta receptor 1 antibody [EPR6244] - BSA and Azide free (AB247992)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

  • Unconjugated

    Anti-Interferon alpha/beta receptor 1 antibody [EPR6244]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR6244

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

In mouse and rat tissue lysates this product detects a band in the region of 100 kDa, however we believe this band is non-specific and is not interferon receptor alpha as the immunogen for this antibody shares only 55% homology with the mouse and rat protein. In addition this band also migrates at a lower molecular weight than that detected in human samples.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

ab247992 is the carrier-free version of ab124764.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Interferon alpha/beta receptor 1 also known as IFNAR1 is an important component of the interferon receptor complex which includes the interferon beta receptor (IFNBR) and the broader class of interferon receptors. IFNAR1 is a transmembrane protein with a molecular mass of approximately 100 kDa. It shows expression in various tissues but predominantly in cells of the immune system. This expression pattern enables IFNAR1 to play a central role in mediating responses to interferon alpha and beta which are cytokines important in the immune response.
Biological function summary

IFNAR1 partners with interferon alpha receptor 2 (IFNAR2) to form a functional receptor complex. This complex binds interferons alpha and beta triggering signal transduction cascades vital for antiviral defense. Through this interaction IFNAR1 facilitates cellular immune responses including the activation of antiviral genes and modulation of cell proliferation. IFNAR1's role extends beyond immediate immune response influencing processes like cell differentiation and apoptosis.

Pathways

IFNAR1 is a participant in the JAK-STAT signaling pathway a significant pathway for transmitting cytokine signals. Upon interferon binding it activates the associated Janus kinases (JAKs) which in turn phosphorylate signal transducers and activators of transcription (STATs) specifically STAT1 and STAT2. This chain of events results in the transcription of interferon-stimulated genes that provide antiviral defenses and promote immune regulation. IFNAR1's engagement in these pathways makes it an integral part of immune system communication.

IFNAR1 associates strongly with autoimmune diseases and viral infections. In lupus an autoimmune disorder dysregulation in interferon signaling involving IFNAR1 contributes to disease progression. Moreover in viral infections like hepatitis C the response of IFNAR1 to interferon therapies can influence treatment outcomes. Understanding these connections facilitates therapeutic strategies that target interferon pathways for improved disease management.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Together with IFNAR2, forms the heterodimeric receptor for type I interferons (including interferons alpha, beta, epsilon, omega and kappa) (PubMed : 10049744, PubMed : 14532120, PubMed : 15337770, PubMed : 2153461, PubMed : 21854986, PubMed : 24075985, PubMed : 31270247, PubMed : 33252644, PubMed : 35442418, PubMed : 7813427). Type I interferon binding activates the JAK-STAT signaling cascade, resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response (PubMed : 10049744, PubMed : 21854986, PubMed : 7665574). Mechanistically, type I interferon-binding brings the IFNAR1 and IFNAR2 subunits into close proximity with one another, driving their associated Janus kinases (JAKs) (TYK2 bound to IFNAR1 and JAK1 bound to IFNAR2) to cross-phosphorylate one another (PubMed : 21854986, PubMed : 32972995, PubMed : 7665574, PubMed : 7813427). The activated kinases phosphorylate specific tyrosine residues on the intracellular domains of IFNAR1 and IFNAR2, forming docking sites for the STAT transcription factors (PubMed : 21854986, PubMed : 32972995, PubMed : 7526154, PubMed : 7665574, PubMed : 7813427). STAT proteins are then phosphorylated by the JAKs, promoting their translocation into the nucleus to regulate expression of interferon-regulated genes (PubMed : 19561067, PubMed : 21854986, PubMed : 32972995, PubMed : 7665574, PubMed : 7813427, PubMed : 9121453). Can also act independently of IFNAR2 : form an active IFNB1 receptor by itself and activate a signaling cascade that does not involve activation of the JAK-STAT pathway (By similarity).
See full target information IFNAR1

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Journal of virology 97:e0190722 PubMed36946735

2023

Characterization of the Impact of Merkel Cell Polyomavirus-Induced Interferon Signaling on Viral Infection.

Applications

Unspecified application

Species

Unspecified reactive species

Ranran Wang,June F Yang,Taylor E Senay,Wei Liu,Jianxin You

Clinics (Sao Paulo, Brazil) 77:100019 PubMed35397366

2022

IRF4 suppresses osteogenic differentiation of BM-MSCs by transcriptionally activating miR-636/DOCK9 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Xuepu Zhang,Yue Zhang,Limin Yang,Yuexin Wu,Xiaohu Ma,Gang Tong,Zhaoliang Ban,Haosen Zhao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com